Intra-articular injection should only be performed by a physician.
Do not use disinfectants containing quaternary ammonium salts or chlorhexidine to prepare the skin, as precipitation of hyaluronic acid is possible in their presence.
The possible presence of an air bubble does not compromise the characteristics of the product.
The injection site must be located on healthy skin. Inject only into the joint space. Do not inject intravascularly or outside the tendon sheath. Do not inject outside the joint space, into the synovial tissue or the joint capsule. Extra-articular infiltration of Sinovial, or outside the tendon sheath, may cause local adverse effects. Do not use Sinovial in the presence of significant intra-articular effusion.
Do not resterilize. Syringe and needles are for single use only. Do not reuse to avoid contamination.
The contents of the pre-filled syringe are sterile. The syringe and needle are supplied in a sealed blister pack. The outer surface of the syringe is not sterile.
As with any invasive joint procedure, it is recommended that the patient refrain from physical exertion after the joint injection and only resume normal activities after a few days.
Adverse reactions:
Associated manifestations such as pain, warmth, redness or swelling may occur at the injection site after the use of Sinovial.
Ice applied to the treated joint may relieve such associated events. These usually subside within a short time.
The patient should inform the physician of any adverse effects that may occur later.
Interactions :
No interactions with other drugs have been reported to date.